These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 34211089

  • 1. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Li Y, Fei H, Lin Q, Liang F, You Y, Li M, Wu M, Qu Y, Li P, Yuan Y, Chen T, Jiang H.
    Oncogene; 2021 Aug; 40(32):5131-5141. PubMed ID: 34211089
    [Abstract] [Full Text] [Related]

  • 2. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA, Todeschini P, Siegel ER, Calza S, Cappella P, Ardighieri L, Cadei M, Bugatti M, Romani C, Bandiera E, Zanotti L, Tassone L, Guarino D, Santonocito C, Capoluongo ED, Beltrame L, Erba E, Marchini S, D'Incalci M, Donzelli C, Santin AD, Pecorelli S, Sartori E, Bignotti E, Odicino F, Ravaggi A.
    J Exp Clin Cancer Res; 2017 May 08; 36(1):63. PubMed ID: 28482906
    [Abstract] [Full Text] [Related]

  • 3. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z, Tian X, Wang R, Cheng X, Mi J, Xiong L, Wang Y, Deng J, Jia M.
    Int J Gynecol Cancer; 2017 Sep 08; 27(7):1343-1349. PubMed ID: 30814239
    [Abstract] [Full Text] [Related]

  • 4. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
    Samardzija C, Luwor RB, Volchek M, Quinn MA, Findlay JK, Ahmed N.
    Mol Cancer; 2015 Aug 11; 14():152. PubMed ID: 26260289
    [Abstract] [Full Text] [Related]

  • 5. Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.
    Park SH, Song JY, Kim YK, Heo JH, Kang H, Kim G, An HJ, Kim TH.
    Int J Oncol; 2014 Mar 11; 44(3):637-46. PubMed ID: 24378809
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-377 Counteracts With Cancer Stem Cell Phenotypes and Epithelial Mesenchymal Transformation by Targeting ZEB2 in Colon Cancer.
    Shayimu P, Yusufu A, Rehemutula A, Redati D, Jiapaer R, Tuerdi R.
    Technol Cancer Res Treat; 2020 Mar 11; 19():1533033820967475. PubMed ID: 33084522
    [Abstract] [Full Text] [Related]

  • 7. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H, Yu T, Han Y, Jiang H, Wang C, You T, Zhao X, Shan H, Yang R, Yang L, Shan H, Gu Y.
    Mol Cancer; 2018 Aug 11; 17(1):119. PubMed ID: 30098599
    [Abstract] [Full Text] [Related]

  • 8. International Federation of gynecology and obstetrics staging classification for cancer of the ovary, fallopian tube, and peritoneum: estimation of survival in patients with node-positive epithelial ovarian cancer.
    Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Peregrin I, Mendizabal E, Ortiz-Quintana L.
    Int J Gynecol Cancer; 2015 Jan 11; 25(1):49-54. PubMed ID: 25405578
    [Abstract] [Full Text] [Related]

  • 9. Long Non-coding RNA HOXA11 Antisense Promotes Cell Proliferation and Invasion and Predicts Patient Prognosis in Serous Ovarian Cancer.
    Yim GW, Kim HJ, Kim LK, Kim SW, Kim S, Nam EJ, Kim YT.
    Cancer Res Treat; 2017 Jul 11; 49(3):656-668. PubMed ID: 27737536
    [Abstract] [Full Text] [Related]

  • 10. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H, Sang M, Liu F, Ai N, Geng C.
    Pathol Res Pract; 2019 Apr 11; 215(4):697-704. PubMed ID: 30611621
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q, Guo R, Lin M, Zhou B, Wang Y.
    Gynecol Oncol; 2011 Jul 11; 122(1):149-54. PubMed ID: 21529905
    [Abstract] [Full Text] [Related]

  • 12. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M, Yu N.
    Tohoku J Exp Med; 2017 Mar 11; 241(3):239-247. PubMed ID: 28344213
    [Abstract] [Full Text] [Related]

  • 13. miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.
    Lu YM, Shang C, Ou YL, Yin D, Li YN, Li X, Wang N, Zhang SL.
    Med Oncol; 2014 Aug 11; 31(8):134. PubMed ID: 25052237
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1.
    Jin M, Yang Z, Ye W, Xu H, Hua X.
    PLoS One; 2014 Aug 11; 9(8):e103965. PubMed ID: 25090005
    [Abstract] [Full Text] [Related]

  • 15. Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome.
    Auer K, Bachmayr-Heyda A, Aust S, Sukhbaatar N, Reiner AT, Grimm C, Horvat R, Zeillinger R, Pils D.
    Oncotarget; 2015 Jul 10; 6(19):17261-75. PubMed ID: 25991672
    [Abstract] [Full Text] [Related]

  • 16. LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
    Mao TL, Fan MH, Dlamini N, Liu CL.
    Int J Mol Sci; 2021 Sep 22; 22(19):. PubMed ID: 34638541
    [Abstract] [Full Text] [Related]

  • 17. Long non coding RNA OIP5‑AS1 promotes metastasis of breast cancer via miR‑340‑5p/ZEB2 axis.
    Meng L, Yue X, Zhou D, Li H.
    Oncol Rep; 2020 Oct 22; 44(4):1662-1670. PubMed ID: 32945479
    [Abstract] [Full Text] [Related]

  • 18. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY, Hu FW, Yu CC, Tsai LL, Yu CH, Wu BC, Chen YW, Huang PI, Lo WL.
    Oral Oncol; 2013 Jan 22; 49(1):34-41. PubMed ID: 22892238
    [Abstract] [Full Text] [Related]

  • 19. Stage IIIC ovarian/peritoneal serous carcinoma: a heterogeneous group of patients with different prognoses.
    Bakkar R, Gershenson D, Fox P, Vu K, Zenali M, Silva E.
    Int J Gynecol Pathol; 2014 May 22; 33(3):302-8. PubMed ID: 24681743
    [Abstract] [Full Text] [Related]

  • 20. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ, Lin XJ, Tang XY, Zheng TT, Zhang XY, Hua KQ.
    Int J Cancer; 2020 May 01; 146(9):2588-2598. PubMed ID: 31577838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.